Skip to main content

Table 1 Summary of anthropometric and biochemical data obtained in the whole study population, in the euthyroid metformin-treated obese diabetic subpopulation (OB-EuM) and the euthyroid obese metformin-untreated subpopulation (Ob-Eu)

From: The impact of the metabolic phenotype on thyroid function in obesity

Variables

Whole population (n = 952)

OB-EuM (n = 306)

Ob-Eu (n = 646)

p

Males/females

410/542

127/179

283/363

0.5

Age (years)

56 (49–65)

58 (50–65)

55 (48–65)

0.07

BMI (kg/m2)

44.4 (40.5–48.9)

45.6 (41.4–49.6)

43.7 (40.0–48.7)

0.003

Weight (kg)

117.8 (102.8–133.5)

118.3 (106.0–134.0)

117.3 (101.6–133.1)

0.09

Height (cm)

161.8 (155–171)

161 (155–170)

162 (155–171)

0.3

Waist (cm)

129 (119–138)

131 (122–140)

127 (116–137)

<0.001

Waist-to-hip ratio

0.96 (0.89–1.92)

0.97 (0.91–1.04)

0.94 (0.88–1.02)

<0.001

REE (kcal/day)

1909 (1651–2247)

1963 (1740–2280)

1884 (1598–2233)

0.003

Fat mass (%)

46.3 (41.0–51.8)

47.3 (41.9–52.6)

45.7 (40.4–51.3)

0.009

Body water (%)

39.7 (36.2–44.2)

39.5 (36.3–43.9)

39.8 (36.2–44.4)

0.7

TSH (mIU/L)

1.72 (1.21–2.47)

1.72 (1.19–2.45)

1.72 (1.22–2.47)

0.7

fT4 (nmol/L)

146.3 (132.5–162.1)

151.9 (135.1–163.5)

145.4 (131.3–162.2)

<0.001

Insulin (pmol/L)

100.7 (65.9–145.8)

98.6 (62.5–150.0)

102.1 (68.1–143.1)

0.5

Glucose (mmol/L)

5.77 (5.05–7.21)

7.38 (6.05–8.99)

5.38 (5.38–6.22)

<0.001

HbA1c (%)

6.6 (6.0–7.9)

7.5 (6.5–8.7)

6.1 (5.7–6.7)

<0.001

HOMA-IR

4.0 (2.5–6.1)

4.7 (2.9–7.2)

3.7 (2.3–5.6)

<0.001

HOMA-B

125.2 (72.1–214.1)

76.3 (42.6–133.1)

152.0 (97.1–248.3)

<0.001

Cholesterol (mmol/L)

5.10 (4.38–5.80)

4.79 (4.01–5.44)

5.26 (4.66–5.98)

<0.001

LDL (mmol/L)

3.12 (2.49–3.76)

2.75 (2.16–3.39)

3.30 (2.70–3.93)

<0.001

HDL (mmol/L)

1.09 (0.91–1.35)

1.04 (0.85–1.27)

1.11 (0.93–1.37)

<0.001

Triglycerides (mmol/L)

1.59 (1.23–2.18)

1.73 (1.31–2.37)

1.55 (1.20–2.09)

<0.001

AST (μkat/L)

0.35 (0.28–0.48)

0.35 (0.28–0.50)

0.35 (0.30–0.48)

0.8

ALT (μkat/L)

0.45 (0.32–0.70)

0.43 (0.32–0.70)

0.45 (0.32–0.70)

0.8

γGT (μkat/L)

0.48 (0.32–0.75)

0.50 (0.33–0.87)

0.47 (0.30–0.72)

0.07

ALP (μkat/L)

1.64 (1.14–3.02)

1.25 (1.04–1.65)

2.27 (1.25–3.35)

<0.001

CRP (nmol/L)

5.71 (2.86–10.48)

5.71 (2.86–11.43)

5.71 (3.81–10.48)

0.5

Fibrinogen (μmol/L)

11.64 (10.17–13.38)

11.44 (9.91–13.17)

11.76 (10.29–13.52)

0.04

  1. HbA1c levels in Ob-Eu refer to measurement in a subgroup of 290 patients. Data are expressed as medians (with interquartile range in parentheses). Comparison between populations was performed by Mann–Whitney test on log-transformed data and χ2 test
  2. BMI body mass index; REE resting energy expenditure; HOMA-IR homeostatic model of insulin resistance; HOMA-B homeostatic model of β cell function; LDL low density lipoprotein; HDL high density lipoprotein; AST aspartate aminotransferase; ALT alanine aminotransferase; γGT gamma glutamiltransferase; ALP alkaline phosphatase; CRP C-reactive protein